Yanmei Zou

Wuhan, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

Identification of prognostic biomarkers and immunotherapy response predictors in lung adenocarcinoma: integrative Mendelian randomization and machine learning analysis.

Identification of prognostic biomarkers and immunotherapy response predictors in lung adenocarcinoma: integrative Mendelian randomization and machine learning analysis.

Journal: Translational lung cancer research

Published: March 17, 2026

Human Gallbladder Cancer Organoids.

Human Gallbladder Cancer Organoids.

Journal: Cell proliferation

Published: March 02, 2026

Human Pancreatic Cancer Organoids.

Human Pancreatic Cancer Organoids.

Journal: Cell proliferation

Published: March 02, 2026

Reprogramming of nitrogen metabolism in tumors: mechanisms and therapeutic implications.

Reprogramming of nitrogen metabolism in tumors: mechanisms and therapeutic implications.

Journal: Amino acids

Published: October 12, 2025

Exploring synthetic lethality in cancer therapy: CRISPR-Cas9 technology offers new hope.

Exploring synthetic lethality in cancer therapy: CRISPR-Cas9 technology offers new hope.

Journal: Biochimica et biophysica acta. Reviews on cancer

Published: July 04, 2024

A methylation-related signature for predicting prognosis and sensitivity to first-line therapies in gastric cancer.

A methylation-related signature for predicting prognosis and sensitivity to first-line therapies in gastric cancer.

Journal: Journal of gastrointestinal oncology

Published: September 14, 2023

Multi-omics consensus portfolio to refine the classification of lung adenocarcinoma with prognostic stratification, tumor microenvironment, and unique sensitivity to first-line therapies.

Multi-omics consensus portfolio to refine the classification of lung adenocarcinoma with prognostic stratification, tumor microenvironment, and unique sensitivity to first-line therapies.

Journal: Translational lung cancer research

Published: October 09, 2022

Integration of molecular pathology with histopathology to accurately evaluate the biological behaviour of WHO grade 2 meningiomas and patient prognosis.

Integration of molecular pathology with histopathology to accurately evaluate the biological behaviour of WHO grade 2 meningiomas and patient prognosis.

Journal: Journal of neuro-oncology

Published: September 16, 2022

Efficacy and Safety of Stereotactic Body Radiotherapy Combined with Camrelizumab and Apatinib in Patients with Hepatocellular Carcinoma with Portal Vein Tumor Thrombus.

Efficacy and Safety of Stereotactic Body Radiotherapy Combined with Camrelizumab and Apatinib in Patients with Hepatocellular Carcinoma with Portal Vein Tumor Thrombus.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: August 21, 2022

Efficacy and safety of low-dose apatinib plus S-1 versus regorafenib and fruquintinib for refractory metastatic colorectal cancer: a retrospective cohort study.

Efficacy and safety of low-dose apatinib plus S-1 versus regorafenib and fruquintinib for refractory metastatic colorectal cancer: a retrospective cohort study.

Journal: Journal of gastrointestinal oncology

Published: March 04, 2022

A Framework to Predict the Molecular Classification and Prognosis of Breast Cancer Patients and Characterize the Landscape of Immune Cell Infiltration.

A Framework to Predict the Molecular Classification and Prognosis of Breast Cancer Patients and Characterize the Landscape of Immune Cell Infiltration.

Journal: Computational and mathematical methods in medicine

Published: November 28, 2021

KRASG12C mutation-induced TOPK overexpression contributes to tumour progression in non-small cell lung cancer.

KRASG12C mutation-induced TOPK overexpression contributes to tumour progression in non-small cell lung cancer.

Journal: Journal of cellular and molecular medicine

Published: September 29, 2021

Showing 1-12 of 31

Last Updated: 09/26/2026